- 全部删除
 
您的购物车当前为空
JW 55 (JW55) 是一种有效且选择性的 β-catenin 信号通路抑制剂,通过抑制 tankyrase 1 和 tankyrase 2 (TNKS1/2) 的 PARP 结构域起作用。


为众多的药物研发团队赋能,
让新药发现更简单!
JW 55 (JW55) 是一种有效且选择性的 β-catenin 信号通路抑制剂,通过抑制 tankyrase 1 和 tankyrase 2 (TNKS1/2) 的 PARP 结构域起作用。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 5 mg | ¥ 119  | In stock | |
| 10 mg | ¥ 208  | In stock | |
| 25 mg | ¥ 413  | In stock | |
| 50 mg | ¥ 672  | In stock | |
| 100 mg | ¥ 1,090  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 137  | In stock | 
JW 55 相关产品
| 产品描述 | JW 55 (JW55) is an effective and selective β-catenin signaling pathway inhibitor, works by inhibition of the PARP domain of tankyrase 1 and tankyrase 2 (TNKS1/2).  | 
| 靶点活性 |  TNKS1 (auto-PARsylation):1.9 μM, TNKS2 (auto-PARsylation):830 nM  | 
| 体外活性 | JW55是一种针对经典Wnt通路的强效且选择性的抑制剂。在Wnt3a诱导并瞬时转染有ST-Luc(SuperTop-萤火虫素酶)报告基因的HEK293细胞中,JW55展现出以IC50值为470 nM的抑制作用。在SW480细胞中,JW55在1至5μM范围内有效;而在HCT-15细胞中,有效范围扩展至0.01至5μM[1]。  | 
| 体内活性 | JW 55(100 mg/kg,口服)减缓了条件性Apc基因敲除小鼠的肿瘤发展。JW 55减少了Xenopus胚胎中XWnt8诱导的轴向复制和Tamoxifen诱导的条件性APC突变小鼠中的息肉形成[1]。  | 
| 细胞实验 | JW 55 (JW55) is prepared in DMSO and stored, and then diluted with appropriate medium[1]. A total of 1,000 SW480 or RKO cells are seeded in 96-well plates. The day after, the cell culture medium is exchanged to solutions that contained 0.1% DMSO or 10 μM JW55 for RKO cells and 0.1% DMSO or 10, 5, or 1 μM JW55 for SW480 cells. All samples consist of a minimum of 6 replicates. The plate is incubated in an IncuCyte inside a cell culture incubator. Images are captured every second hour to monitor proliferation[1].  | 
| 别名 | JW55 | 
| 分子量 | 434.48 | 
| 分子式 | C25H26N2O5 | 
| CAS No. | 664993-53-7 | 
| Smiles | COc1ccc(cc1)C1(CNC(=O)c2ccc(NC(=O)c3ccco3)cc2)CCOCC1 | 
| 密度 | 1.235 g/cm3 (Predicted) | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 100 mM, Sonication is recommended.  DMSO: 50 mg/mL (115.08 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.6 mM), Sonication is recommended.  请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容